Vitality Watch

Dossier pubmed review 15-jul-2026
Narrative review or expert overview without new data

Osteoimmune senescence in aging-related bone diseases.

Key claim: Aging-related bone diseases share overlapping osteoimmune senescence mechanisms in which senescent skeletal cells, chronic SASP signaling, and impaired immune clearance uncouple bone remodeling and impair repair.

Abstract

Aging-related bone diseases are increasingly recognized as disorders in which uncoupled bone remodeling remains central but is substantially modified by immune-skeletal interactions. This review consolidates current evidence for osteoimmune senescence, a framework that links senescent skeletal cells, aging immune compartments, chronic SASP signaling, impaired immune clearance, and marrow-niche deterioration to reduced bone strength and repair. Osteoporosis, rheumatoid arthritis-associated erosion, osteoarthritis, periodontal bone loss, and delayed fracture healing are clinically distinct diseases, but they may share overlapping senescence-associated osteoimmune mechanisms while retaining disease-specific endotypes. Senescent osteocytes, osteoblast-lineage cells, and bone marrow stromal cells can increase RANKL/OPG imbalance, suppress osteogenesis, and reshape immune recruitment, whereas remodeled T cells, macrophages, neutrophils, and NK-cell surveillance pathways modify osteoclastogenesis and repair resolution. We also discuss gut-derived metabolites and imaging phenotypes as clinically important but non-specific readouts of this biology. DXA, HR-pQCT, MRI, CBCT, and molecular imaging cannot identify senescent cells directly, but they can anchor molecular hypotheses to tissue-level deterioration. Therapeutic translation will depend on matching senolytics, senomorphics, immune-recalibrating approaches, microbiota-derived metabolites, and bone-targeted delivery systems to disease stage, dominant cell population, and measurable skeletal endpoints.

Why this matters

Osteoimmune senescence packages several previously siloed bone diseases — osteoporosis, OA, RA erosion, periodontal loss, delayed fracture healing — under one mechanistic substrate of senescent skeletal cells, persistent SASP, and failed immune clearance. If the framework holds, it predicts that senolytic/senomorphic and immune-restorative approaches now being tested for systemic aging will have overlapping targets in skeletal disease, and that bone endpoints become plausible readouts for geroscience trials. The gap between this conceptual consolidation and any human bone-outcome trial remains large.

Source

Link

Briefing card

Osteoimmune senescence in aging-related bone diseases.
Stage: review · pubmed · 15-jul-2026

Aging-related bone diseases share overlapping osteoimmune senescence mechanisms in which senescent skeletal cells, chronic SASP signaling, and impaired immune clearance uncouple bone remodeling and impair repair.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.3389/fimmu.2026.1892334

build build 880 · 2bcef25 · 2026-11-18